BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 19028280)

  • 1. Sphere of equivalence--a novel target volume concept for intraoperative radiotherapy using low-energy X rays.
    Herskind C; Griebel J; Kraus-Tiefenbacher U; Wenz F
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1575-81. PubMed ID: 19028280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boost.
    Vaidya JS; Baum M; Tobias JS; Massarut S; Wenz F; Murphy O; Hilaris B; Houghton J; Saunders C; Corica T; Roncadin M; Kraus-Tiefenbacher U; Melchaert F; Keshtgar M; Sainsbury R; Douek M; Harrison E; Thompson A; Joseph D
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1335-8. PubMed ID: 17084562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mathematical modelling of radiotherapy strategies for early breast cancer.
    Enderling H; Anderson AR; Chaplain MA; Munro AJ; Vaidya JS
    J Theor Biol; 2006 Jul; 241(1):158-71. PubMed ID: 16386275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TARGIT trial: targeted intraoperative radiation therapy versus conventional postoperative whole-breast radiotherapy after breast-conserving surgery for the management of early-stage invasive breast cancer (a trial update).
    Holmes DR; Baum M; Joseph D
    Am J Surg; 2007 Oct; 194(4):507-10. PubMed ID: 17826067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Partial breast irradiation: high dose rate peroperative brachytherapy technique using the MammoSite].
    Belkacémi Y; Chauvet MP; Giard S; Poupon L; Castellanos ME; Villette S; Bonodeau F; Cabaret V; Lartigau E
    Cancer Radiother; 2003 Nov; 7 Suppl 1():129s-136s. PubMed ID: 15124555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term toxicity of an intraoperative radiotherapy boost using low energy X-rays during breast-conserving surgery.
    Kraus-Tiefenbacher U; Bauer L; Scheda A; Fleckenstein K; Keller A; Herskind C; Steil V; Melchert F; Wenz F
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):377-81. PubMed ID: 16887294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of accelerated partial breast irradiation.
    Mitsumori M; Hiraoka M
    Breast Cancer; 2008; 15(1):101-7. PubMed ID: 18224403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative Biologic Effectiveness (RBE) of 50 kV X-rays measured in a phantom for intraoperative tumor-bed irradiation.
    Liu Q; Schneider F; Ma L; Wenz F; Herskind C
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1127-33. PubMed ID: 22981707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated partial breast irradiation: consensus statement of 3 German Oncology societies.
    Sauer R; Sautter-Bihl ML; Budach W; Feyer P; Harms W; Souchan R; Wollwiener D; Kreienberg R; Wenz F
    Cancer; 2007 Sep; 110(6):1187-94. PubMed ID: 17647249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated breast conservation and intraoperative radiation therapy.
    Orecchia R; Ivaldi GB; Leonardi MC
    Breast; 2009 Oct; 18 Suppl 3():S98-102. PubMed ID: 19914553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologically effective dose-response relationship for breast cancer treated by conservative surgery and postoperative radiotherapy.
    Plataniotis GA; Dale RG
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):512-7. PubMed ID: 19625139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial.
    Vaidya JS; Joseph DJ; Tobias JS; Bulsara M; Wenz F; Saunders C; Alvarado M; Flyger HL; Massarut S; Eiermann W; Keshtgar M; Dewar J; Kraus-Tiefenbacher U; Sütterlin M; Esserman L; Holtveg HM; Roncadin M; Pigorsch S; Metaxas M; Falzon M; Matthews A; Corica T; Williams NR; Baum M
    Lancet; 2010 Jul; 376(9735):91-102. PubMed ID: 20570343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: a matched-pair analysis with 10-year follow-up.
    Antonucci JV; Wallace M; Goldstein NS; Kestin L; Chen P; Benitez P; Dekhne N; Martinez A; Vicini F
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):447-52. PubMed ID: 19058921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative biological effectiveness of photon energies used in brachytherapy and intraoperative radiotherapy techniques for two breast cancer cell lines.
    Marthinsen AB; Gisetstad R; Danielsen S; Frengen J; Strickert T; Lundgren S
    Acta Oncol; 2010 Nov; 49(8):1261-8. PubMed ID: 20735284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Accelerated partial breast irradiation following breast conservative surgery. A review of the literature].
    Calais G
    Cancer Radiother; 2003 Nov; 7 Suppl 1():124s-128s. PubMed ID: 15124554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The less than whole breast radiotherapy approach.
    Lehman M; Hickey B
    Breast; 2010 Jun; 19(3):180-7. PubMed ID: 20511068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial breast irradiation using targeted intraoperative radiotherapy (Targit).
    Vaidya JS
    Nat Clin Pract Oncol; 2007 Jul; 4(7):384-5. PubMed ID: 17549089
    [No Abstract]   [Full Text] [Related]  

  • 19. Partial-breast treatment for early breast cancer: emergence of a new paradigm.
    Sarin R
    Nat Clin Pract Oncol; 2005 Jan; 2(1):40-7. PubMed ID: 16264855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Accelerated partial breast irradiation using interstitial high dose rate brachytherapy: preliminary clinical and dosimetric results after 61 patients].
    Hannoun-Levi JM; Ferré M; Raoust I; Lallement M; Flipo B; Ettore F; Marcié S
    Cancer Radiother; 2008 Nov; 12(6-7):532-40. PubMed ID: 18835737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.